Peregrine Pharma (PPHM) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Total costs and expenses: 16.69M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total costs and expenses: 16.69M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Peregrine Pharma (NASDAQ: PPHM) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $10.75 million versus the consensus estimate of $14 million.
GUIDANCE:
Peregrine Pharma sees FY2017 revenue of $60-65 million.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
